#United States #Boston #Prendio #BioProcure #Larry Birch

Prendio and BioProcure Welcome Larry Birch as New CEO

On March 17, 2026, Prendio and BioProcure, prominent players in the procurement and financial management arena for life sciences, announced the appointment of Laurence "Larry" Birch as their new Chief Executive Officer. This strategic move comes as both companies aim to expand their technological capabilities and enhance the services provided to biotechnology and pharmaceutical firms.

Prendio and BioProcure specialize in offering a unique blend of procurement software, financial workflow tools, and supplier network solutions specifically designed for organizations within the life sciences sector. Collectively, these companies present a powerful combination of high-touch service and sophisticated software that enables research-centric organizations to streamline their purchasing processes, gain enhanced financial visibility, and achieve greater operational efficiency.

The existing platform currently supports hundreds of burgeoning and mid-range biotechnology firms across the United States, managing significant research and operational expenditures—totaling billions—while aiding innovative startups in extending their cash runway through strategic engagements with suppliers.

Birch emphasized the challenges faced by biotech companies, noting that capital efficiency, transparency, and speed have become increasingly crucial in today's complex environment. He stated, "Prendio and BioProcure have developed a compelling platform that connects life sciences companies to the necessary tools, suppliers, and financial infrastructure required for effective operations. I am eager to collaborate with the team to expand our capabilities further and to continue crafting solutions that assist our clients in delivering new therapies to patients more efficiently."

With a wealth of experience in leadership roles across life sciences, technology-enabled services, and private-equity-backed growth companies, Birch has a proven track record of advising and steering organizations within the biotechnology sphere. His contributions throughout his career include scaling platforms that bolster research, development, and commercialization processes.

Phil Molner, Managing Partner of Primus Capital and a board member at Prendio, expressed confidence in Birch’s ability to not only lead the companies forward but also advance the value proposition that Prendio and BioProcure provide to the life sciences community, enhancing the quality, speed, and cost-effectiveness of their research activities.

In his role as CEO, Birch's primary focus will lie in expanding the technological landscape of the companies, fortifying relationships with biotechnology and pharmaceutical clients, and creating new solutions designed to facilitate more effective management of purchasing, financial operations, and supplier partnerships.

For over two decades, Prendio and BioProcure have been the trusted partners of biotechnology firms in modernizing their procurement and financial operations. By integrating specialized software with curated supplier networks and inherent life sciences knowledge, these firms simplify the procurement process, heighten financial control, and expedite scientific advancements.

About Prendio

Prendio operates as a cloud-based procure-to-pay platform tailored specifically to the needs of biotechnology and life sciences organizations. Its capabilities allow firms to manage procurement, approvals, suppliers, and financial workflows in a proficient environment that caters to research-driven teams.

About BioProcure

BioProcure functions as a group purchasing organization dedicated to the biotechnology sector. It assists companies in accessing preferred supplier pricing, streamlining procurement and accounts payable processes while reducing operational costs, thereby accelerating research and development efforts.